Welcome to the Jorgensen Lab
For the past thirty years, the Jorgensen Research Group has been at the forefront of computational chemistry and molecular design. Below is an outline of our progress:
| 1976-82 | QM studies of organic ions & ion-molecule complexes |
|---|---|
| 1978- | MC for liquids, OPLS force field development |
| 1980- | Solvent effects on conformational equilibria |
| 1980-95 | Development of CAMEO for prediction of products of organic reactions |
| 1983 | TIP3P & TIP4P water models |
| 1984 | Free-energy profiles for SN2 reactions in solution |
| 1985 | 1st FEP calculation: CH3CH3 --> CH3OH in water |
| 1985- | FEP for reactions in solution (QM + MM), ΔGhyd, ion-pairing, pKas, log P, hydrophobic effects, etc. |
| 1988-96 | Molecular recognition/organic host-guest complexes |
| 1989 | Secondary electrostatic effects for G-C, A-T, etc. |
| 1987- | MD and MC for proteins, denaturation, folding, enzymatic rxns |
| 1996- | FEP/MC for protein-ligand binding |
| 1997- | Full QM/MM for organic & enzymatic reactions |
| 2000- | Structure-based drug design, ADME predictions |
| 2001- | Semiempirical molecular orbital method development |
| 2003- | FEP-guided design and synthesis of enzyme inhibitors |
Newest Publications
357.
Investigation of Solvent Effects on the Rate and Stereoselectivity of the Henry Reactio
n.
Kostal, J.; Voutchkova, A. M.; Jorgensen, W. L.
Org. Lett.
2012,
14,
260-263.
doi:10.1021/ol2030394.
356.
Computationally-Guided Optimization of a Docking Hit to Yield Catechol Diethers as Pote
nt Anti-HIV Agents.
Bollini, M.; Domaoal, R. A.; Thakur, V. V.; Gallardo-Macias, R.; Spasov, K. A.; Ander
son, K. S.; Jorgensen, W. L.
J. Med. Chem.
2011,
54,
8582-8591.
doi:10.1021/jm201134m.
355.
Improving MM-GB/SA Scoring through the Application of the Variable Dielectric Model.
Ravindranathan, K.; Tirado-Rives, J.; Jorgensen, W. L.; Guimaraes, C. R. W.
J. Chem. Theory Comput.
2011,
7,
3859-3865.
doi:10.1021/ct200565u.
354.
On the Mechanism and Rate of Spontaneous Decomposition of Amino Acids.
Alexandrova, A. N.; Jorgensen, W. L.
J. Phys. Chem. B
2011,
115,
13624-13932.
doi:10.1021/jp2081808.
353.
Efficient Discovery of Potent Anti-HIV Agents Targeting the Tyr181Cys Variant of HIV Reverse Transcri
ptase.
Jorgensen, W. L.; Bollini, M.; Thakur, V. V.; Domaoal, R. A.; Spasov, K. A.; Anderson, K. S.
J. Am. Chem. Soc.
2011,
133,
15686-15696.
doi:10.1021/ja2058583.
352.
Benzisothiazolones as modulators of macrophage migration inhibitory factor.
Jorgensen, W. L.; Trofimov, A.; Du, X.; Hare, A. A.; Leng, L.; Bucala, R.
Bioorg. Med. Chem. Lett.
2011,
21,
4545-4549.
doi:10.1016/j.bmcl.2011.05.127.
351.
Aryl extensions of thienopyrimidinones as fibroblast growth factor receptor 1 kinase inhibitors.
Ekkati, A. R.; Mandiyan, V.; Ravindranathan, K. P.; Bae, J. H.; Schlessinger, J.; Jorgensen, W. L.
Tetrahedron Lett.
2011,
52,
2228-2231.
doi:10.1016/j.tetlet.2010.12.081.
350.
Limiting Cardiac Ischemic Injury by Augmenting the MIF-AMPK Signaling Cascade with a Novel Class of MIF Receptor Agonists.
Wang, J.; Yan, X.; Yeung, E.; Gandavadi, S.; Hare, A.; Du, X.; Leng, L.; Jorgensen, W. L.; Bucala, R.
Circulation
2010,
122,
A15835.
For more details about the specifics of the research, please see the publications page and the research page.

